healthcare

Another weekly gain, inflation headwinds, Kogan canned, IPOs pulled The ASX200 (ASX:XJO) finished Friday on a positive note, up 0.2%, delivering a weekly gain of the same amount. For the day, only the materials and energy sectors finished lower, the latter on concerns of a boost in supply from Iran. The consumer staples and healthcare sectors were…

ASX delivers small gain, Future Fund leads renewables deal  The ASX200 (ASX:XJO) finished slightly higher, adding 0.1% to commence the week.  The IT sector continues to feel a great deal of selling pressure with Afterpay (ASX:APT) falling another 4.5% as investors continue to pivot towards more sustainable, undervalued sources of returns. The share price is now nearly 30% off…

ASX to open higher, strong US lead, Commonwealth Bank (ASXLCBA) hit with ASIC investigation The ASX200 (ASX:XJO) finished 1.7% higher to start the week, rebounding quickly from Friday’s so-called ‘bloodbath’. Once again, market volatility was met with reassuring language from central banks and positive news around the vaccine rollout. The Reserve Bank of Australia confirmed that they would be…

According to Martin Currie chief investment officer Reece Birtles, the timing “could not be better for ‘value’ stocks.” This is a theme reiterated by the likes of Andrew Clifford of Platinum Asset Management this week, who described markets as being gripped with “speculative mania in high-growth stocks” in a world that has “gone crazy.” Birtles’…

An interview with Will Baylis, Portfolio Management of Sustainable Equity at Martin Currie. Thank you so much for joining us Will, it would be great to get an insight into what you are seeing for the year ahead and to take our readers through the opportunities and challenges that lie ahead.  Starting on a more…

With attention focused on the record-breaking run of the Dow Jones Industrial Average (DJIA), which now sits above 30,000 points for the first time, smaller companies continue to be neglected. Yet with the Russell 2000 currently over 20% higher in November alone, perhaps the tide is beginning to turn. One of the core premises of…

Long-short strategies, which involve giving a fund manager the flexibility to profit when share prices rise or fall, were gaining traction before the pandemic. The trend has continued to accelerate since, but they remain an under-represented part of most investor portfolios. Whether due to a lack of understanding or perceived higher risk, heightened equity market…

Executive summary Societies and governments around the world are looking at a COVID-19 vaccine as the panacea that will enable the world to recover, reconnect and regain our way of life. Since the genetic code for COVID-19 was unlocked, researchers have set out in an unprecedented and coordinated effort to make a vaccine available on…

Markets to open higher, ASX up 1.3% on the back of CSL (ASX: CSL), National Australia Bank (ASX: NAB) profit crushed, ‘Nirvana’ for sharemarkets. The ASX 200 (ASX: XJO) delivered another strong day as it became more clear that Joe Biden would be the next President of the United States. Despite the election still being…

And still they keep coming – here’s the fourth instalment of our series on the fascinating ASX cohort of medical device developers. As always, don’t let the impressive sexiness of the technology persuade you on its own that these stocks are headed for the stars. In each of the three cases presented here, previous investors…